sftd

SHP-1, New Protein Target of Type 2 Diabetes Treatment

Filed in archive Studies , Treatment on June 16, 2006

SHP-1, New Protein Target of Type 2 Diabetes Treatment
The unsuspected role of a protein named SHP-1 that could constitute a new therapeutic path against Type 2 diabetes have been identified by a research study funded by the Canadian Institutes of Health Research (CIHR) and the Canadian Diabetes Association (CDA).

It has been known to the researchers that SHP-1 played a role in regulating the immune system but nobody verified if this protein was involved on the regulation of metabolism. In a mice study, the research team looked into this.

"Our results indicate that these mice are extremely sensitive to insulin and, consequently, they are very effective in metabolising glucose at the level of the liver and the muscles," notes Andr・Marette. In addition, the researchers highlighted that SHP-1 inhibits the decomposition of insulin by the liver. "This could explain the increase in the insulin concentrations of certain metabolic disorders associated with obesity," indicates the researcher.


Through this protein (SHP-1), doors will open in the search for potential treatment of type 2 diabetes.

Read more at EurekAlert.

Permalink: SHP-1, New Protein Target of Type 2 Diabetes Treatment

Tags: type  2  diabetes  treatment  protein  type+diabetes  diabetes+treatment  target+type 

Vote for SHP-1, New Protein Target of Type 2 Diabetes Treatment:

  • Currently 8.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.00 out of 4 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Allergies   Alzheimer's Disease   Arthritis   Bacteria and Bacterial Infections   Best of   Blog Carnivals   Bone Health   Cancer   Cardiovascular Health   Cases   CFS   Consumer Alert   Controversies   Dental Health   Diabetes   Diagnostics   Diarrhea   Did you know   Diet   Dietary Supplements and Vitamins